Synapse - Larry Norton

Results (762)

CALGB 9840: Phase III study of weekly (W) paclitaxel (P) via 1-hour(h) infusion versus standard (S) 3h infusion every third week in the treatment of metastatic breast cancer (MBC), with trastuzumab (T) for HER2 positive MBC and randomized for T in HER2 normal MBC

Meeting Abstract

Seidman, A. D.; Berry, D.; Cirrincione, C.; Harris, L.; Dressler, L.; Muss, H.; Norton, L.; Winer, E.; Hudis, C.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

Feasibility of breast conserving treatment for breast cancer in women with germline BRCA mutations: A clinic-based series

Meeting Abstract

Robson, M.; Holcombe, T.; McCormick, B.; Borgen, P.; Gulati, T.; Jhanwar, S.; Kauff, N.; Hudis, C.; Norton, L.; Offit, K.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

How to integrate new therapies to our current strategies

Meeting Abstract

Norton, L.
EJC Supplements (2004)

Fulltext@MSK | Save

Toward the development of molecular oncology: The integration of molecular epidemiology and environmental oncology

Meeting Abstract

Norton, L.
Epidemiology (2004)

Fulltext@MSK | Save

Gene sets driving tissue-specific breast cancer metastasis

Meeting Abstract

Massague, J.; Kang, Y.; Siegel, P. M.; Shu, W. P.; Minn, A.; Gupta, G.; Cordon-Cardo, C.; Guise, T. A.; VanPoznak, C.; Norton, L.
Journal of Bone and Mineral Research (2004)

Fulltext@MSK | Save

Efficacy of a mitochondrial toxin, F16, in a multi-ATP-depleting regimen plus chemotherapy on human breast cancer (MDA-MB-468) xenografts

Meeting Abstract

Martin, D. S.; Alfieri, A.; Koutcher, J.; Fantin, V.; Spriggs, D.; Norton, L.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

Incidence of ovarian cancer in BRCA-negative hereditary breast cancer families

Meeting Abstract

Kauff, N.; Cigler, T.; Hurley, K.; Huang, H.; Rapaport, H.; Wadsworth, E.; Robson, M.; Norton, L.; Barakat, R.; Offit, K.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

Phase I dose-finding study of weekly (W) docetaxel (T) followed by flavopiridol (F) for patients with metastatic solid tumors

Meeting Abstract

Fornier, M. N.; Rathkopf, D.; Shah, M.; Hudis, C.; O'reilly, E.; Kortmansky, J.; Winkelmann, J.; Kelsen, D.; Norton, L.; Schwartz, G. K.
Annals of Oncology (2004)

Fulltext@MSK | Save

Phase II trial of erlotinib (OSI-774), an epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor, and bevacizumab, a recombinant humanized monoclonal antibody to vascular endothelial growth factor (VEGF), in patients (pts) with metastatic breast cancer (MBC)

Meeting Abstract

Dickler, M.; Rugo, H.; Caravelli, J.; Brogi, E.; Sachs, D.; Panageas, K.; Flores, S.; Moasser, M.; Norton, L.; Hudis, C.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: Cancer and Leukemia Group B Trial 9342

Journal Article

Winer, E. P.; Berry, D. A.; Woolf, S.; Duggan, W.; Kornblith, A.; Harris, L. N.; Michaelson, R. A.; Kirshner, J. A.; Fleming, G. F.; Perry, M. C.; more...
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save